Cancer Genetics Announces Closing of Public Offering of 1,500,000 Shares of Common Stock
19 août 2013 12h50 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Aug. 19, 2013 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a diagnostics company focused on developing genomic-based, oncology tests and services, today announced the...
Cancer Genetics Announces Pricing of Public Offering of 1,500,000 Shares of Common Stock
13 août 2013 19h29 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Aug. 13, 2013 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a diagnostics company focused on developing genomic-based, oncology tests and services, today announced the...
Cancer Genetics Announces Second Quarter 2013 Financial Results
05 août 2013 07h35 HE
|
Cancer Genetics, Inc.
Quarterly Revenue Growth Accelerates to 60% YoY
Excluding Grant Revenue, Quarterly Revenue Grew 90% YoY
Gross Margin Improved to 30% From 5% in the Year Ago Period
Quarterly Clinical Test Volume...
Cancer Genetics, Inc. Named To the 2012 Inc. 500|5000 List
04 sept. 2012 11h11 HE
|
Cancer Genetics, Inc.
Rutherford, NJ, Sept. 4, 2012 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (CGI), a leader in oncology-focused
personalized medicine, today announced that Inc. magazine ranked
the company #232 among...